Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.15)
# 1,154
Out of 4,944 analysts
465
Total ratings
40.38%
Success rate
2.32%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HUMA Humacyte | Maintains: Buy | $4 → $3 | $1.80 | +67.13% | 2 | Aug 12, 2025 | |
MIRM Mirum Pharmaceuticals | Maintains: Buy | $73 → $80 | $64.72 | +23.61% | 2 | Aug 7, 2025 | |
DCTH Delcath Systems | Maintains: Buy | $29 → $31 | $10.88 | +184.93% | 14 | Aug 7, 2025 | |
PSNL Personalis | Maintains: Buy | $9 → $8.5 | $4.57 | +86.00% | 16 | Aug 6, 2025 | |
CELC Celcuity | Maintains: Buy | $27 → $50 | $50.06 | -0.12% | 8 | Jul 28, 2025 | |
AEMD Aethlon Medical | Assumes: Neutral | $1.5 | $1.26 | +19.05% | 1 | Jul 7, 2025 | |
VOR Vor Biopharma | Upgrades: Buy | $3 | $1.66 | +80.72% | 13 | Jun 30, 2025 | |
NUVL Nuvalent | Maintains: Buy | $110 → $130 | $76.67 | +69.56% | 4 | Jun 24, 2025 | |
OCGN Ocugen | Reiterates: Buy | $7 | $1.03 | +579.61% | 22 | Jun 24, 2025 | |
ETON Eton Pharmaceuticals | Maintains: Buy | $33 → $35 | $17.32 | +102.08% | 8 | May 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $90 | $4.25 | +2,017.65% | 1 | May 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $18.82 | +64.72% | 19 | May 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.16 | - | 7 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.04 | +380.77% | 9 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.10 | +172.73% | 3 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.11 | - | 12 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $19.94 | +100.60% | 6 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.62 | +225.15% | 15 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $73.59 | +97.04% | 22 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $3.04 | +1,873.68% | 15 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $7 | $2.58 | +171.32% | 16 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 → $11 | $2.07 | +431.40% | 16 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.02 | +147.52% | 11 | Apr 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.85 | +391.23% | 12 | Apr 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.23 | +56.95% | 4 | Apr 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $1.36 | +1,297.06% | 14 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.32 | - | 15 | Mar 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.80 | +233.33% | 10 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.97 | +135.69% | 14 | Mar 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $8.67 | +130.68% | 1 | Mar 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.25 | +7,900.00% | 15 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.48 | +458.04% | 13 | Mar 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.71 | +1,741.62% | 7 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.27 | +188.42% | 12 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $36.54 | +64.20% | 18 | Feb 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.22 | +357.06% | 18 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.15 | +249.22% | 11 | Nov 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.29 | +1,601.84% | 2 | Nov 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.75 | - | 2 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.23 | +52.14% | 8 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.48 | +706.45% | 1 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $6.04 | +49.01% | 1 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.45 | - | 2 | Aug 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.86 | - | 12 | May 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.53 | +488.24% | 1 | Feb 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $3.06 | +716.99% | 2 | Jan 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.91 | +161.78% | 1 | Dec 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $4.61 | +2,503.04% | 1 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.81 | +562.98% | 2 | Aug 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.37 | +5,303.94% | 2 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.10 | - | 8 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $4.50 | +33.33% | 4 | Jul 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $2.42 | +519.83% | 5 | Nov 9, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $8.21 | +301.95% | 1 | Mar 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $15.72 | -39.57% | 3 | Mar 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.33 | +1,052,531.58% | 1 | Mar 5, 2020 |
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.80
Upside: +67.13%
Mirum Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $73 → $80
Current: $64.72
Upside: +23.61%
Delcath Systems
Aug 7, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $10.88
Upside: +184.93%
Personalis
Aug 6, 2025
Maintains: Buy
Price Target: $9 → $8.5
Current: $4.57
Upside: +86.00%
Celcuity
Jul 28, 2025
Maintains: Buy
Price Target: $27 → $50
Current: $50.06
Upside: -0.12%
Aethlon Medical
Jul 7, 2025
Assumes: Neutral
Price Target: $1.5
Current: $1.26
Upside: +19.05%
Vor Biopharma
Jun 30, 2025
Upgrades: Buy
Price Target: $3
Current: $1.66
Upside: +80.72%
Nuvalent
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $76.67
Upside: +69.56%
Ocugen
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.03
Upside: +579.61%
Eton Pharmaceuticals
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $17.32
Upside: +102.08%
May 27, 2025
Assumes: Buy
Price Target: $90
Current: $4.25
Upside: +2,017.65%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $18.82
Upside: +64.72%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.16
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.04
Upside: +380.77%
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.10
Upside: +172.73%
May 14, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.11
Upside: -
May 13, 2025
Reiterates: Buy
Price Target: $40
Current: $19.94
Upside: +100.60%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.62
Upside: +225.15%
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $73.59
Upside: +97.04%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $3.04
Upside: +1,873.68%
May 2, 2025
Maintains: Buy
Price Target: $1.5 → $7
Current: $2.58
Upside: +171.32%
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $2.07
Upside: +431.40%
Apr 11, 2025
Reiterates: Buy
Price Target: $5
Current: $2.02
Upside: +147.52%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $2.85
Upside: +391.23%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.23
Upside: +56.95%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $1.36
Upside: +1,297.06%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.32
Upside: -
Mar 20, 2025
Reiterates: Buy
Price Target: $6
Current: $1.80
Upside: +233.33%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.97
Upside: +135.69%
Mar 17, 2025
Initiates: Buy
Price Target: $20
Current: $8.67
Upside: +130.68%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.25
Upside: +7,900.00%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.48
Upside: +458.04%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.71
Upside: +1,741.62%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $24.27
Upside: +188.42%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $36.54
Upside: +64.20%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $7.22
Upside: +357.06%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $3.15
Upside: +249.22%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.29
Upside: +1,601.84%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.75
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.23
Upside: +52.14%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $2.48
Upside: +706.45%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $6.04
Upside: +49.01%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.45
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.86
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.53
Upside: +488.24%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $3.06
Upside: +716.99%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.91
Upside: +161.78%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $4.61
Upside: +2,503.04%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.81
Upside: +562.98%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.37
Upside: +5,303.94%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $15.10
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $4.50
Upside: +33.33%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $2.42
Upside: +519.83%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $8.21
Upside: +301.95%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $15.72
Upside: -39.57%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.33
Upside: +1,052,531.58%